{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:04:45Z","timestamp":1774875885111,"version":"3.50.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Dorothea Dix Fellowship Fund"},{"name":"Kopf Foundation Fellowship Fund"},{"name":"Gary R. Helman Postdoctoral Research Fellowship"},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA018151"],"award-info":[{"award-number":["R01 DA018151"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00213-019-05444-4","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T11:02:51Z","timestamp":1578481371000},"page":"1147-1160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat"],"prefix":"10.1007","volume":"237","author":[{"given":"Marta","family":"Valenza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7713-4512","authenticated-orcid":false,"given":"Kyle A","family":"Windisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo R.","family":"Butelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Jeanne","family":"Kreek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"key":"5444_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1126\/science.282.5387.298","volume":"282","author":"SH Ahmed","year":"1998","unstructured":"Ahmed SH, Koob GF (1998) Transition from moderate to excessive drug intake: change in hedonic set point. Science 282:298\u2013300","journal-title":"Science"},{"key":"5444_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00213-005-2180-z","volume":"180","author":"SH Ahmed","year":"2005","unstructured":"Ahmed SH, Koob GF (2005) Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function. Psychopharmacology 180:473\u2013490","journal-title":"Psychopharmacology"},{"key":"5444_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neubiorev.2015.06.012","volume":"56","author":"F Allain","year":"2015","unstructured":"Allain F, Minogianis EA, Roberts DC, Samaha AN (2015) How fast and how often: the pharmacokinetics of drug use are decisive in addiction. Neurosci Biobehav Rev 56:166\u2013179","journal-title":"Neurosci Biobehav Rev"},{"key":"5444_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pbb.2009.12.005","volume":"95","author":"GA Angarita","year":"2010","unstructured":"Angarita GA, Pittman B, Gueorguieva R, Kalayasiri R, Lynch WJ, Sughondhabirom A, Morgan PT, Malison RT (2010) Regulation of cocaine self-administration in humans: lack of evidence for loading and maintenance phases. Pharmacol Biochem Behav 95:51\u201355","journal-title":"Pharmacol Biochem Behav"},{"key":"5444_CR5","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/BF02532378","volume":"21","author":"S Archer","year":"1996","unstructured":"Archer S, Glick SD, Bidlack JM (1996) Cyclazocine revisited. Neurochem Res 21:1369\u20131373","journal-title":"Neurochem Res"},{"key":"5444_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/BF02246021","volume":"125","author":"HMT Barros","year":"1996","unstructured":"Barros HMT, Miczek KA (1996) Withdrawal from oral cocaine in rats: ultrasonic vocalizations and tactile startle. Psychopharmacology 125:379\u2013384","journal-title":"Psychopharmacology"},{"key":"5444_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","volume":"183","author":"PM Beardsley","year":"2005","unstructured":"Beardsley PM, Howard JL, Shelton KL, Carroll FI (2005) Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology 183:118\u2013126","journal-title":"Psychopharmacology"},{"key":"5444_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00213-010-1846-3","volume":"210","author":"PM Beardsley","year":"2010","unstructured":"Beardsley PM, Pollard GT, Howard JL, Carroll FI (2010) Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl ]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats. Psychopharmacology 210:189\u2013198","journal-title":"Psychopharmacology"},{"key":"5444_CR9","doi-asserted-by":"crossref","unstructured":"Becker-Krail D, McClung C (2016) Implications of circadian rhythm and stress in addiction vulnerability. F1000Res 5: 59","DOI":"10.12688\/f1000research.7608.1"},{"key":"5444_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0006-8993(96)00713-5","volume":"736","author":"T Belej","year":"1996","unstructured":"Belej T, Manji D, Sioutis S, Barros HM, Nobrega JN (1996) Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects. Brain Res 736:287\u2013296","journal-title":"Brain Res"},{"key":"5444_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0006-8993(98)00670-2","volume":"804","author":"JJ Bouyer","year":"1998","unstructured":"Bouyer JJ, Vallee M, Deminiere JM, Le Moal M, Mayo W (1998) Reaction of sleep-wakefulness cycle to stress is related to differences in hypothalamo-pituitary-adrenal axis reactivity in rat. Brain Res 804:114\u2013124","journal-title":"Brain Res"},{"key":"5444_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jama.1985.03360010087032","volume":"254","author":"MA Bozarth","year":"1985","unstructured":"Bozarth MA, Wise RA (1985) Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA 254:81\u201383","journal-title":"JAMA"},{"key":"5444_CR13","doi-asserted-by":"publisher","first-page":"29803","DOI":"10.1074\/jbc.M705540200","volume":"282","author":"MR Bruchas","year":"2007","unstructured":"Bruchas MR, Yang T, Schreiber S, Defino M, Kwan SC, Li S, Chavkin C (2007) Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase. J Biol Chem 282:29803\u201329811","journal-title":"J Biol Chem"},{"key":"5444_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2012.05.005","volume":"35","author":"ER Butelman","year":"2012","unstructured":"Butelman ER, Yuferov V, Kreek MJ (2012) Kappa-opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction. Trends Neurosci 35:587\u2013596","journal-title":"Trends Neurosci"},{"key":"5444_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejphar.2004.08.028","volume":"501","author":"I Carroll","year":"2004","unstructured":"Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, Harris LS (2004) Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Eur J Pharmacol 501:111\u2013119","journal-title":"Eur J Pharmacol"},{"key":"5444_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/npp.2015.226","volume":"41","author":"EH Chartoff","year":"2016","unstructured":"Chartoff EH, Ebner SR, Sparrow A, Potter D, Baker PM, Ragozzino ME, Roitman MF (2016) Relative timing between kappa opioid receptor activation and cocaine determines the impact on reward and dopamine release. Neuropsychopharmacology 41:989\u20131002","journal-title":"Neuropsychopharmacology"},{"key":"5444_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/BF02245810","volume":"120","author":"CA Crawford","year":"1995","unstructured":"Crawford CA, McDougall SA, Bolanos CA, Hall S, Berger SP (1995) The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity. Psychopharmacology 120:392\u2013399","journal-title":"Psychopharmacology"},{"key":"5444_CR18","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41386-018-0015-y","volume":"43","author":"E Domi","year":"2018","unstructured":"Domi E, Barbier E, Augier E, Augier G, Gehlert D, Barchiesi R, Thorsell A, Holm L, Heilig M (2018) Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders. Neuropsychopharmacology 43:1805\u20131812","journal-title":"Neuropsychopharmacology"},{"key":"5444_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/FBP.0000000000000155","volume":"26","author":"RJ Donahue","year":"2015","unstructured":"Donahue RJ, Landino SM, Golden SA, Carroll FI, Russo SJ, Carlezon WA Jr (2015) Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin\/kappa-opioid receptor system. Behav Pharmacol 26:654\u2013663","journal-title":"Behav Pharmacol"},{"key":"5444_CR20","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2174\/138161211795656738","volume":"17","author":"PJ Edge","year":"2011","unstructured":"Edge PJ, Gold MS (2011) Drug withdrawal and hyperphagia: lessons from tobacco and other drugs. Curr Pharm Des 17:1173\u20131179","journal-title":"Curr Pharm Des"},{"key":"5444_CR21","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/nn1579","volume":"8","author":"BJ Everitt","year":"2005","unstructured":"Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8:1481\u20131489","journal-title":"Nat Neurosci"},{"key":"5444_CR22","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1046\/j.1460-9568.2003.02636.x","volume":"17","author":"P Fagergren","year":"2003","unstructured":"Fagergren P, Smith HR, Daunais JB, Nader MA, Porrino LJ, Hurd YL (2003) Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self-administration. Eur J Neurosci 17:2212\u20132218","journal-title":"Eur J Neurosci"},{"key":"5444_CR23","doi-asserted-by":"publisher","first-page":"e66438","DOI":"10.1371\/journal.pone.0066438","volume":"8","author":"E Falcon","year":"2013","unstructured":"Falcon E, Ozburn A, Mukherjee S, Roybal K, McClung CA (2013) Differential regulation of the period genes in striatal regions following cocaine exposure. PLoS One 8:e66438","journal-title":"PLoS One"},{"key":"5444_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.2042-7158.1994.tb03761.x","volume":"46","author":"YK Fung","year":"1994","unstructured":"Fung YK, Richard LA (1994) Behavioural consequences of cocaine withdrawal in rats. J Pharm Pharmacol 46:150\u2013152","journal-title":"J Pharm Pharmacol"},{"key":"5444_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0193-953X(18)30614-2","volume":"9","author":"F Gawin","year":"1986","unstructured":"Gawin F, Kleber H (1986) Pharmacologic treatments of cocaine abuse. Psychiatr Clin North Am 9:573\u2013583","journal-title":"Psychiatr Clin North Am"},{"key":"5444_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00213-007-1067-6","volume":"197","author":"BJ Gehrke","year":"2008","unstructured":"Gehrke BJ, Chefer VI, Shippenberg TS (2008) Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum. Psychopharmacology 197:509\u2013517","journal-title":"Psychopharmacology"},{"key":"5444_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0006-8993(95)00306-B","volume":"681","author":"SD Glick","year":"1995","unstructured":"Glick SD, Maisonneuve IM, Raucci J, Archer S (1995) Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681:147\u2013152","journal-title":"Brain Res"},{"key":"5444_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0014-2999(98)00548-2","volume":"357","author":"SD Glick","year":"1998","unstructured":"Glick SD, Visker KE, Maisonneuve IM (1998) Effects of cyclazocine on cocaine self-administration in rats. Eur J Pharmacol 357:9\u201314","journal-title":"Eur J Pharmacol"},{"key":"5444_CR29","first-page":"150","volume":"275","author":"CA Heidbreder","year":"1995","unstructured":"Heidbreder CA, Babovic-Vuksanovic D, Shoaib M, Shippenberg TS (1995) Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists. J Pharmacol Exp Ther 275:150\u2013163","journal-title":"J Pharmacol Exp Ther"},{"key":"5444_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0006-8993(93)90228-F","volume":"616","author":"CA Heidbreder","year":"1993","unstructured":"Heidbreder CA, Goldberg SR, Shippenberg TS (1993) The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res 616:335\u2013338","journal-title":"Brain Res"},{"key":"5444_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/(SICI)1098-2396(199811)30:3<255::AID-SYN3>3.0.CO;2-A","volume":"30","author":"CA Heidbreder","year":"1998","unstructured":"Heidbreder CA, Schenk S, Partridge B, Shippenberg TS (1998) Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist. Synapse 30:255\u2013262","journal-title":"Synapse"},{"key":"5444_CR32","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/00001756-199409080-00028","volume":"5","author":"CA Heidbreder","year":"1994","unstructured":"Heidbreder CA, Shippenberg TS (1994) U-69593 prevents cocaine sensitization by normalizing basal accumbens dopamine. Neuroreport 5:1797\u20131800","journal-title":"Neuroreport"},{"key":"5444_CR33","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/j.1471-4159.1988.tb03103.x","volume":"51","author":"YL Hurd","year":"1988","unstructured":"Hurd YL, Kehr J, Ungerstedt U (1988) In vivo microdialysis as a technique to monitor drug transport: correlation of extracellular cocaine levels and dopamine overflow in the rat brain. J Neurochem 51:1314\u20131316","journal-title":"J Neurochem"},{"key":"5444_CR34","first-page":"3","volume":"41","author":"CE Johanson","year":"1989","unstructured":"Johanson CE, Fischman MW (1989) The pharmacology of cocaine related to its abuse. Pharmacol Rev 41:3\u201352","journal-title":"Pharmacol Rev"},{"key":"5444_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF03188784","volume":"17","author":"EK Johansson","year":"1992","unstructured":"Johansson EK, Tucker SM, Ginn HB, Martin BR, Aceto MD (1992) Functional and dispositional tolerance develops during continuous cocaine exposure. Eur J Drug Metab Pharmacokinet 17:155\u2013162","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"5444_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","volume":"35","author":"GF Koob","year":"2010","unstructured":"Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217\u2013238","journal-title":"Neuropsychopharmacology"},{"key":"5444_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0376-8716(98)00064-7","volume":"51","author":"MJ Kreek","year":"1998","unstructured":"Kreek MJ, Koob GF (1998) Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51:23\u201347","journal-title":"Drug Alcohol Depend"},{"key":"5444_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0014-2999(98)00637-2","volume":"358","author":"AV Kuzmin","year":"1998","unstructured":"Kuzmin AV, Gerrits MA, Van Ree JM (1998) Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naive rats. Eur J Pharmacol 358:197\u2013202","journal-title":"Eur J Pharmacol"},{"key":"5444_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0014-2999(96)00961-2","volume":"321","author":"AV Kuzmin","year":"1997","unstructured":"Kuzmin AV, Semenova S, Gerrits MA, Zvartau EE, Van Ree JM (1997) Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur J Pharmacol 321:265\u2013271","journal-title":"Eur J Pharmacol"},{"key":"5444_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","volume":"28","author":"BB Land","year":"2008","unstructured":"Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008) The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28:407\u2013414","journal-title":"J Neurosci"},{"key":"5444_CR41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1037\/a0036268","volume":"128","author":"RW Logan","year":"2014","unstructured":"Logan RW, Williams WP 3rd, McClung CA (2014) Circadian rhythms and addiction: mechanistic insights and future directions. Behav Neurosci 128:387\u2013412","journal-title":"Behav Neurosci"},{"key":"5444_CR42","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.brainres.2008.02.106","volume":"1213","author":"WJ Lynch","year":"2008","unstructured":"Lynch WJ, Girgenti MJ, Breslin FJ, Newton SS, Taylor JR (2008) Gene profiling the response to repeated cocaine self-administration in dorsal striatum: a focus on circadian genes. Brain Res 1213:166\u2013177","journal-title":"Brain Res"},{"key":"5444_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0304-3940(94)90559-2","volume":"181","author":"IM Maisonneuve","year":"1994","unstructured":"Maisonneuve IM, Archer S, Glick SD (1994) U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci Lett 181:57\u201360","journal-title":"Neurosci Lett"},{"key":"5444_CR44","first-page":"239","volume":"294","author":"JR Mantsch","year":"2000","unstructured":"Mantsch JR, Schlussman SD, Ho A, Kreek MJ (2000) Effects of cocaine self-administration on plasma corticosterone and prolactin in rats. J Pharmacol Exp Ther 294:239\u2013247","journal-title":"J Pharmacol Exp Ther"},{"key":"5444_CR45","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0306-4530(02)00088-4","volume":"28","author":"JR Mantsch","year":"2003","unstructured":"Mantsch JR, Yuferov V, Mathieu-Kia AM, Ho A, Kreek MJ (2003) Neuroendocrine alterations in a high-dose, extended-access rat self-administration model of escalating cocaine use. Psychoneuroendocrinology 28:836\u2013862","journal-title":"Psychoneuroendocrinology"},{"key":"5444_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00213-004-1778-x","volume":"175","author":"JR Mantsch","year":"2004","unstructured":"Mantsch JR, Yuferov V, Mathieu-Kia AM, Ho A, Kreek MJ (2004) Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats. Psychopharmacology 175:26\u201336","journal-title":"Psychopharmacology"},{"key":"5444_CR47","first-page":"17","volume":"4","author":"A Markou","year":"1991","unstructured":"Markou A, Koob GF (1991) Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 4:17\u201326","journal-title":"Neuropsychopharmacology"},{"key":"5444_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbr.2005.10.004","volume":"168","author":"C Marquez","year":"2006","unstructured":"Marquez C, Nadal R, Armario A (2006) Influence of reactivity to novelty and anxiety on hypothalamic-pituitary-adrenal and prolactin responses to two different novel environments in adult male rats. Behav Brain Res 168:13\u201322","journal-title":"Behav Brain Res"},{"key":"5444_CR49","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1124\/mol.111.074195","volume":"80","author":"EJ Melief","year":"2011","unstructured":"Melief EJ, Miyatake M, Carroll FI, Beguin C, Carlezon WA Jr, Cohen BM, Grimwood S, Mitch CH, Rorick-Kehn L, Chavkin C (2011) Duration of action of a broad range of selective kappa-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation. Mol Pharmacol 80:920\u2013929","journal-title":"Mol Pharmacol"},{"key":"5444_CR50","first-page":"451","volume":"227B","author":"RW Morris","year":"1987","unstructured":"Morris RW (1987) Circadian and circannual rhythms of emergency room drug-overdose admissions. Prog Clin Biol Res 227B:451\u2013457","journal-title":"Prog Clin Biol Res"},{"key":"5444_CR51","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s002130000646","volume":"154","author":"NH Mutschler","year":"2001","unstructured":"Mutschler NH, Covington Iii HE, Miczek KA (2001) Repeated self-administered cocaine \"binges\" in rats: effects on cocaine intake and withdrawal. Psychopharmacology 154:292\u2013300","journal-title":"Psychopharmacology"},{"key":"5444_CR52","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s002130050584","volume":"136","author":"NH Mutschler","year":"1998","unstructured":"Mutschler NH, Miczek KA (1998) Withdrawal from a self-administered or non-contingent cocaine binge: differences in ultrasonic distress vocalizations in rats. Psychopharmacology 136:402\u2013408","journal-title":"Psychopharmacology"},{"key":"5444_CR53","first-page":"556","volume":"196","author":"PK Nayak","year":"1976","unstructured":"Nayak PK, Misra AL, Mule SJ (1976) Physiological disposition and biotransformation of (3H) cocaine in acutely and chronically treated rats. J Pharmacol Exp Ther 196:556\u2013569","journal-title":"J Pharmacol Exp Ther"},{"key":"5444_CR54","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.alcohol.2014.09.034","volume":"49","author":"PK Parekh","year":"2015","unstructured":"Parekh PK, Ozburn AR, McClung CA (2015) Circadian clock genes: effects on dopamine, reward and addiction. Alcohol 49:341\u2013349","journal-title":"Alcohol"},{"key":"5444_CR55","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1126\/science.3016896","volume":"233","author":"A Pfeiffer","year":"1986","unstructured":"Pfeiffer A, Brantl V, Herz A, Emrich HM (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233:774\u2013776","journal-title":"Science"},{"key":"5444_CR56","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00213-010-1899-3","volume":"211","author":"R Picetti","year":"2010","unstructured":"Picetti R, Ho A, Butelman ER, Kreek MJ (2010) Dose preference and dose escalation in extended-access cocaine self-administration in Fischer and Lewis rats. Psychopharmacology 211:313\u2013323","journal-title":"Psychopharmacology"},{"key":"5444_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/02791072.1995.10471670","volume":"27","author":"AE Pottieger","year":"1995","unstructured":"Pottieger AE, Tressell PA, Surratt HL, Inciardi JA, Chitwood DD (1995) Drug use patterns of adult crack users in street versus residential treatment samples. J Psychoactive Drugs 27:27\u201338","journal-title":"J Psychoactive Drugs"},{"key":"5444_CR58","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/npp.2017.245","volume":"43","author":"B Reed","year":"2018","unstructured":"Reed B, Butelman ER, Fry RS, Kimani R, Kreek MJ (2018) Repeated administration of Opra Kappa (LY2456302), a novel, short-acting, selective KOP-r antagonist, in persons with and without cocaine dependence. Neuropsychopharmacology 43:928","journal-title":"Neuropsychopharmacology"},{"key":"5444_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neuroscience.2012.06.006","volume":"220","author":"B Reed","year":"2012","unstructured":"Reed B, Fang N, Mayer-Blackwell B, Chen S, Yuferov V, Zhou Y, Kreek MJ (2012) Chromatin alterations in response to forced swimming underlie increased prodynorphin transcription. Neuroscience 220:109\u2013118","journal-title":"Neuroscience"},{"key":"5444_CR60","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1176\/ajp.131.5.595","volume":"131","author":"R Resnick","year":"1974","unstructured":"Resnick R, Fink M, Freedman AM (1974) High-dose cyclazocine therapy of opiate dependence. Am J Psychiatry 131:595\u2013597","journal-title":"Am J Psychiatry"},{"key":"5444_CR61","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s002130050293","volume":"131","author":"DC Roberts","year":"1997","unstructured":"Roberts DC, Andrews MM (1997) Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure. Psychopharmacology 131:271\u2013277","journal-title":"Psychopharmacology"},{"key":"5444_CR62","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0376-8716(02)00083-2","volume":"67","author":"DCS Roberts","year":"2002","unstructured":"Roberts DCS, Brebner K, Vincler M, Lynch WJ (2002) Patterns of cocaine self-administration in rats produced by various access conditions under a discrete trials procedure. Drug Alcohol Depend 67:291\u2013299","journal-title":"Drug Alcohol Depend"},{"key":"5444_CR63","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neuropharm.2013.09.021","volume":"77","author":"LM Rorick-Kehn","year":"2014","unstructured":"Rorick-Kehn LM, Witkin JM, Statnick MA, Eberle EL, McKinzie JH, Kahl SD, Forster BM, Wong CJ, Li X, Crile RS, Shaw DB, Sahr AE, Adams BL, Quimby SJ, Diaz N, Jimenez A, Pedregal C, Mitch CH, Knopp KL, Anderson WH, Cramer JW, McKinzie DL (2014) LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders. Neuropharmacology 77:131\u2013144","journal-title":"Neuropharmacology"},{"key":"5444_CR64","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s002130051016","volume":"144","author":"S Schenk","year":"1999","unstructured":"Schenk S, Partridge B, Shippenberg TS (1999) U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology 144:339\u2013346","journal-title":"Psychopharmacology"},{"key":"5444_CR65","first-page":"545","volume":"276","author":"TS Shippenberg","year":"1996","unstructured":"Shippenberg TS, LeFevour A, Heidbreder C (1996) Kappa-opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. J Pharmacol Exp Ther 276:545\u2013554","journal-title":"J Pharmacol Exp Ther"},{"key":"5444_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0014-2999(97)01614-2","volume":"345","author":"TS Shippenberg","year":"1998","unstructured":"Shippenberg TS, LeFevour A, Thompson AC (1998) Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the \u03ba-opioid receptor agonist U69593. Eur J Pharmacol 345:27\u201334","journal-title":"Eur J Pharmacol"},{"key":"5444_CR67","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/archpsyc.63.3.324","volume":"63","author":"R Sinha","year":"2006","unstructured":"Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ (2006) Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63:324\u2013331","journal-title":"Arch Gen Psychiatry"},{"key":"5444_CR68","first-page":"818","volume":"250","author":"SP Sivam","year":"1989","unstructured":"Sivam SP (1989) Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J Pharmacol Exp Ther 250:818\u2013824","journal-title":"J Pharmacol Exp Ther"},{"key":"5444_CR69","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0169-328X(95)00319-N","volume":"38","author":"R Spangler","year":"1996","unstructured":"Spangler R, Ho A, Zhou Y, Maggos CE, Yuferov V, Kreek MJ (1996) Regulation of kappa opioid receptor mRNA in the rat brain by \u2018binge\u2019 pattern cocaine administration and correlation with preprodynorphin mRNA. Mol Brain Res 38:71\u201376","journal-title":"Mol Brain Res"},{"key":"5444_CR70","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00213-003-1680-y","volume":"172","author":"MS Todtenkopf","year":"2004","unstructured":"Todtenkopf MS, Marcus JF, Portoghese PS, Carlezon WA Jr (2004) Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology 172:463\u2013470","journal-title":"Psychopharmacology"},{"key":"5444_CR71","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s002130050053","volume":"148","author":"W Tornatzky","year":"2000","unstructured":"Tornatzky W, Miczek KA (2000) Cocaine self-administration \"binges\": transition from behavioral and autonomic regulation toward homeostatic dysregulation in rats. Psychopharmacology 148:289\u2013298","journal-title":"Psychopharmacology"},{"key":"5444_CR72","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1097\/00001756-199408150-00018","volume":"5","author":"EM Unterwald","year":"1994","unstructured":"Unterwald EM, Rubenfeld JM, Kreek MJ (1994) Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport 5:1613\u20131616","journal-title":"Neuroreport"},{"key":"5444_CR73","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1038\/sj.npp.1300254","volume":"28","author":"T Uz","year":"2003","unstructured":"Uz T, Akhisaroglu M, Ahmed R, Manev H (2003) The pineal gland is critical for circadian Period1 expression in the striatum and for circadian cocaine sensitization in mice. Neuropsychopharmacology 28:2117\u20132123","journal-title":"Neuropsychopharmacology"},{"key":"5444_CR74","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1007\/s00213-017-4647-0","volume":"234","author":"M Valenza","year":"2017","unstructured":"Valenza M, Butelman ER, Kreek MJ (2017) Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats. Psychopharmacology 234:2219\u20132231","journal-title":"Psychopharmacology"},{"key":"5444_CR75","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neuropharm.2016.01.004","volume":"105","author":"M Valenza","year":"2016","unstructured":"Valenza M, Picetti R, Yuferov V, Butelman ER, Kreek MJ (2016) Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration. Neuropharmacology 105:639\u2013650","journal-title":"Neuropharmacology"},{"key":"5444_CR76","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJMra1511480","volume":"374","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, Koob GF, McLellan AT (2016) Neurobiologic advances from the brain disease model of addiction. N Engl J Med 374:363\u2013371","journal-title":"N Engl J Med"},{"key":"5444_CR77","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s002130100788","volume":"157","author":"S Walsh","year":"2001","unstructured":"Walsh S, Strain E, Abreu M, Bigelow G (2001) Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology 157:151\u2013162","journal-title":"Psychopharmacology"},{"key":"5444_CR78","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s002130050358","volume":"132","author":"AS Ward","year":"1997","unstructured":"Ward AS, Haney M, Fischman MW, Foltin RW (1997) Binge cocaine self-administration in humans: intravenous cocaine. Psychopharmacology 132:375\u2013381","journal-title":"Psychopharmacology"},{"key":"5444_CR79","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1001\/archpsyc.1990.01810210069010","volume":"47","author":"WW Weddington","year":"1990","unstructured":"Weddington WW, Brown BS, Haertzen CA, Cone EJ, Dax EM, Herning RI, Michaelson BS (1990) Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch Gen Psychiatry 47:861\u2013868","journal-title":"Arch Gen Psychiatry"},{"key":"5444_CR80","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00213-009-1563-y","volume":"205","author":"S Wee","year":"2009","unstructured":"Wee S, Orio L, Ghirmai S, Cashman JR, Koob GF (2009) Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine. Psychopharmacology 205:565\u2013575","journal-title":"Psychopharmacology"},{"key":"5444_CR81","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1124\/jpet.106.113340","volume":"320","author":"S Wee","year":"2007","unstructured":"Wee S, Specio SE, Koob GF (2007) Effects of dose and session duration on cocaine self-administration in rats. J Pharmacol Exp Ther 320:1134\u20131143","journal-title":"J Pharmacol Exp Ther"},{"key":"5444_CR82","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/0006-8993(92)91327-B","volume":"593","author":"F Weiss","year":"1992","unstructured":"Weiss F, Markou A, Lorang MT, Koob GF (1992) Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593:314\u2013318","journal-title":"Brain Res"},{"key":"5444_CR83","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.alcohol.2013.12.007","volume":"48","author":"KA Windisch","year":"2014","unstructured":"Windisch KA, Kosobud AE, Czachowski CL (2014) Intravenous alcohol self-administration in the P rat. Alcohol 48:419\u2013425","journal-title":"Alcohol"},{"key":"5444_CR84","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neuroscience.2016.01.052","volume":"320","author":"GY Zan","year":"2016","unstructured":"Zan GY, Wang Q, Wang YJ, Chen JC, Wu X, Yang CH, Chai JR, Li M, Liu Y, Hu XW, Shu XH, Liu JG (2016) p38 mitogen-activated protein kinase activation in amygdala mediates kappa opioid receptor agonist U50,488H-induced conditioned place aversion. Neuroscience 320:122\u2013128","journal-title":"Neuroscience"},{"key":"5444_CR85","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00213-003-1688-3","volume":"172","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ (2004) Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL\/6J mice. Psychopharmacology 172:422\u2013429","journal-title":"Psychopharmacology"},{"key":"5444_CR86","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1038\/npp.2011.165","volume":"36","author":"BA Zimmer","year":"2011","unstructured":"Zimmer BA, Dobrin CV, Roberts DC (2011) Brain-cocaine concentrations determine the dose self-administered by rats on a novel behaviorally dependent dosing schedule. Neuropsychopharmacology 36:2741\u20132749","journal-title":"Neuropsychopharmacology"},{"key":"5444_CR87","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00213-012-2877-8","volume":"225","author":"BA Zimmer","year":"2013","unstructured":"Zimmer BA, Dobrin CV, Roberts DC (2013) Examination of behavioral strategies regulating cocaine intake in rats. Psychopharmacology 225:935\u2013944","journal-title":"Psychopharmacology"},{"key":"5444_CR88","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/978-1-61779-458-2_18","volume":"829","author":"BA Zimmer","year":"2012","unstructured":"Zimmer BA, Roberts DC (2012) Cocaine self-administration in rats: hold-down procedures. Methods Mol Biol 829:279\u2013290","journal-title":"Methods Mol Biol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05444-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-019-05444-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05444-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:12:14Z","timestamp":1609978334000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-019-05444-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,8]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["5444"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-05444-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,8]]},"assertion":[{"value":"7 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures adhered to the National Institutes of Health <i>Guide for the Care and Use of Laboratory Animals<\/i> and the <i>Principles of Laboratory Animal Care<\/i> and were approved by the Institutional Animal Care and Use Committee of The Rockefeller University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}